Sarepta Stops Stop Shipments of Muscular Dystrophy Gene Therapy After Second Patient Death
A patient has died after receiving Sarepta Therapeutics’ approved gene therapy for Duchenne muscular dystrophy — the second fatality reported ...
A patient has died after receiving Sarepta Therapeutics’ approved gene therapy for Duchenne muscular dystrophy — the second fatality reported ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.Sarepta Therapeutics ...
Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was longer than usual ...
A study using artificial intelligence to classify patient pain archetypes and identify risk for severe pain after knee replacement has ...
Amid market shifts and shallower pockets, health system leaders are restrategizing. Hospitals across the country are juggling new and ongoing ...
You arrive at the scene to find a patient struggling to breathe. They can’t speak clearly, no family is present, ...
Patients’ satisfaction with GP services has collapsed in recent years as family doctors have switched to providing far fewer face-to-face ...
Alcidion unveils genAI apps ASX-listed health IT provider Alcidion has announced new generative AI-based solutions developed in collaboration with Google ...
Operational efficiency relies on understanding the right data. Failing to ensure your healthcare practice is monitoring the correct data means ...
Smell loss was a defining symptom of Covid, and for some people, a curse. Most people regain their sense of ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.